Autolus Therapeutics PLC (AUTL)

14.74 -0.04  -0.27% NASDAQ Dec 6, 20:00 Delayed 2m USD

Autolus Therapeutics Price to Book Value:

2.459 for Dec. 6, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Price to Book Value Chart

Export Data
Save Image
Print Image

Historical Price to Book Value Data

View and export this data going back to 2018. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 6, 2019 2.459
Dec. 5, 2019 2.466
Dec. 4, 2019 2.656
Dec. 3, 2019 2.701
Dec. 2, 2019 2.716
Nov. 29, 2019 2.502
Nov. 27, 2019 2.384
Nov. 26, 2019 2.320
Nov. 25, 2019 2.259
Nov. 22, 2019 2.154
Nov. 21, 2019 2.240
Nov. 20, 2019 2.302
Nov. 19, 2019 2.117
Nov. 18, 2019 1.988
Nov. 15, 2019 1.967
Nov. 14, 2019 1.863
Nov. 13, 2019 1.857
Nov. 12, 2019 1.918
Nov. 11, 2019 2.042
Nov. 8, 2019 2.010
Nov. 7, 2019 2.067
Nov. 6, 2019 2.175
Nov. 5, 2019 2.384
Nov. 4, 2019 2.154
Nov. 1, 2019 2.112
   
Oct. 31, 2019 1.997
Oct. 30, 2019 2.004
Oct. 29, 2019 2.079
Oct. 28, 2019 2.109
Oct. 25, 2019 2.237
Oct. 24, 2019 2.256
Oct. 23, 2019 2.085
Oct. 22, 2019 2.149
Oct. 21, 2019 2.125
Oct. 18, 2019 2.054
Oct. 17, 2019 2.155
Oct. 16, 2019 1.964
Oct. 15, 2019 2.024
Oct. 14, 2019 2.029
Oct. 11, 2019 2.075
Oct. 10, 2019 2.115
Oct. 9, 2019 2.065
Oct. 8, 2019 1.977
Oct. 7, 2019 2.060
Oct. 4, 2019 2.012
Oct. 3, 2019 2.044
Oct. 2, 2019 1.984
Oct. 1, 2019 1.965
Sept. 30, 2019 2.072
Sept. 27, 2019 1.81

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

Price to Book Value Benchmarks

Benchmarks
Mereo BioPharma Group PLC 0.5552
Adaptimmune Therapeutics PLC 0.7976
Verona Pharma PLC 1.016

Price to Book Value Range, Past 5 Years

Minimum 1.477 Aug 12 2019
Maximum 15.16 Nov 09 2018
Average 6.261
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.